Showing results (191-200 of 494) with videos related to
Sort By:
Pageof 50
Clinical Research in Cardiology : Official Journal of the German Cardiac Society|January 27, 2016
Impact of obstructive and central apneas on ventricular repolarisation: lessons learned from studies in man and pigsDominik Linz, Alisa Denner, Susanne Illing, et al.Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|June 10, 2021
Renal denervation in patients with versus without chronic kidney disease: results from the Global SYMPLICITY Registry with follow-up data of 3 yearsChristian Ott, Felix Mahfoud, Giuseppe Mancia, et al.Hypertension (Dallas, Tex. : 1979)|April 4, 2024
Impact of Renal Denervation on Urinary Peptide-Based Biomarkers in HypertensionLucas Lauder, Justyna Siwy, Emmanouil Mavrogeorgis, et al.International Journal of Cardiology|April 1, 2014
Improvement of albuminuria after renal denervationChristian Ott, Felix Mahfoud, Axel Schmid, et al.Trials|December 22, 2015
The renin-angiotensin receptor blocker azilsartan medoxomil compared with the angiotensin-converting enzyme inhibitor ramipril in clinical trials versus routine practice: insights from the prospective EARLY registryPeter Bramlage, Roland E Schmieder, Anselm K Gitt, et al.Contemporary Clinical Trials Communications|July 14, 2021
A re-examination of the SPYRAL HTN-OFF MED Pivotal trial with respect to the underlying model assumptionsMichael Böhm, Martin Fahy, Graeme L Hickey, et al.Journal of the Society for Cardiovascular Angiography & Interventions|August 12, 2024
PEERLESS II: A Randomized Controlled Trial of Large-Bore Thrombectomy Versus Anticoagulation in Intermediate-Risk Pulmonary EmbolismJay Giri, Felix Mahfoud, Bernhard Gebauer, et al.BMC Cardiovascular Disorders|July 4, 2013
EARLY Treatment with azilsartan compared to ACE-inhibitors in anti-hypertensive therapy--rationale and design of the EARLY hypertension registryAnselm K Gitt, Peter Baumgart, Peter Bramlage, et al.American Heart Journal|December 25, 2015
The SPYRAL HTN Global Clinical Trial Program: Rationale and design for studies of renal denervation in the absence (SPYRAL HTN OFF-MED) and presence (SPYRAL HTN ON-MED) of antihypertensive medicationsDavid E Kandzari, Kazuomi Kario, Felix Mahfoud, et al.Journal of Hypertension|May 3, 2019
Safety and efficacy of endovascular ultrasound renal denervation in resistant hypertension: 12-month results from the ACHIEVE studyJoost Daemen, Felix Mahfoud, Karl-Heinz Kuck, et al.Pageof 50